(0)

DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか？ or パスワードをお忘れですか？

Not a Member?

アカウントを作成して参加。

Bethesda North Marriott Hotel and Conference Center

2017年10月25日 (水) 午前 7:00 - 2017年10月26日 (木) 午後 3:30

5701 Marinelli Road, , North Bethesda, MD 20852 , USA

Combination Products Conference

Innovation and New Frontiers

概要

October 24: Short Course: Combination Product Advanced Case Studies
*Lunch not included with Short Course.
October 25-26: Conference

The DIA Combination Products Conference: Innovation and New Frontiers will examine the current regulatory ecosystem for combination product development and approval, including provisions of the 21st Century Cures Act, proposed PDUFA VI commitments, the implementation of new decision-making models at FDA, US regulatory developments, global regulatory changes, and global alignment efforts. In-depth treatment of digital and eHealth issues, labeling for combination products and complex generics, and CGMPs for combination products will be featured.

In an interactive format, relevant stakeholders from FDA and industry will present the challenges and opportunities in combination product development and life cycle management. Participants will take away today’s best answers to these questions: How can the new legal and regulatory tools be used to best advance combination product development and approval? Is the regulatory framework for combination products good enough and how can it be further improved? How can new technologies be leveraged to realize opportunities in development of new therapies to meet patient needs?

Approved by the Regulatory Affairs Professionals Society for 12 RAC credits.

Featured

Want to learn more about Combination Products Conference? You've come to the right site!

Continuing-Education

もっと見る

Exhibits

もっと見る

参加対象

Professionals involved in:

  • Biopharmaceutical, Device, and Combination Product R&D and Development
  • Regulatory Affairs
  • Policy
  • Clinical Research
  • Consulting, Legal, Government Affairs
  • CMC
  • Quality assurance and Control
  • Business Development

学習目的

At the conclusion of this conference, participants should be able to:

  • Examine recently issued guidelines and regulations, including FDA’s latest implementation efforts for 21st Century Cures in the combination product space
  • Discuss the FDA final guidance for combination product GMPs and identify appropriate mechanisms for resolving GMP-related questions for combination products
  • Describe the challenges associated with global registration of combination products and regulatory strategies for navigating differing requirements in different countries
  • Explain recent regulatory changes for digital health products and their impact on digital health drug/device combination products
  • Identify challenges associated with establishing bioequivalence for generic products, as well as for combination products

Short Course or Primer

To keep you at the forefront.

2017年10月24日 (火)

Course:

Combination Product Advanced Case Studies

もっと見る

プログラム委員会

  • Rachel Turow, JD, MPH
    Rachel Turow, JD, MPH Managing Counsel, FDA Regulatory
    Walmart, Inc., United States
  • Nathan Brown, JD
    Nathan Brown, JD Health Care and Life Sciences Partner
    Akin Gump Strauss Hauer & Feld LLP, United States
  • Carla Cartwright, JD, LLM
    Carla Cartwright, JD, LLM Director, Federal Affairs
    Johnson & Johnson, United States
  • Kirsten H. Paulson, MS, RAC
    Kirsten H. Paulson, MS, RAC
    Pfizer, Inc., United States
  • Kim Quaintance-Lunn
    Kim Quaintance-Lunn Vice President, Head of Regulatory Science and Execution
    Alexion, United States
  • John Weiner, JD
    John Weiner, JD Associate Director for Policy, Office of Combination Products, OCPP, OC
    FDA, United States

Digital Learning Catalog

DIA Learning: eLearning Soultions
Download

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。